|
|
Volumn 14, Issue , 2014, Pages
|
|
Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BOCEPREVIR;
TELAPREVIR;
COST EFFECTIVENESS ANALYSIS;
DISEASE DURATION;
DRUG EFFICACY;
EUROPE;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HEALTH CARE POLICY;
HEALTH EDUCATION;
HEPATITIS C;
HIGH RISK BEHAVIOR;
HIGH RISK POPULATION;
HUMAN;
INFECTION CONTROL;
MISCELLANEOUS NAMED GROUPS;
NOTE;
PEOPLE WHO INJECT DRUGS;
PRACTICE GUIDELINE;
PREVALENCE;
PUBLIC HEALTH CAMPAIGN;
SCREENING TEST;
SOCIAL DISCRIMINATION;
SOCIAL STIGMA;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
COMPLICATION;
MASS SCREENING;
SUBSTANCE ABUSE;
TRANSMISSION;
EUROPE;
HEALTH POLICY;
HEPATITIS C;
HUMANS;
MASS SCREENING;
PREVALENCE;
SUBSTANCE ABUSE, INTRAVENOUS;
|
|
EID: 84929518027
PISSN: None
EISSN: 14712334
Source Type: Journal
DOI: 10.1186/1471-2334-14-S6-S3 Document Type: Note |
|
Times cited : (3)
|
|
References (6)
|
